drugset / Trial / NCT00851864

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

NCT00851864

Phase 4 Completed 13 enrolled University of Calgary LEO Pharma · collab
NaSingle-groupOpen-label

Summary

The purpose of this study is to evaluate the safety and efficacy of therapeutic anticoagulation with tinzaparin during pregnancy via weight-based dosing.

Timeline

Start
2007-10
Primary completion
2010-10
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Tinzaparin Other / unclassified 175 iu/kg Subcutaneous